266 related articles for article (PubMed ID: 9054386)
1. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor.
Maddox JF; Hachicha M; Takano T; Petasis NA; Fokin VV; Serhan CN
J Biol Chem; 1997 Mar; 272(11):6972-8. PubMed ID: 9054386
[TBL] [Abstract][Full Text] [Related]
2. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
3. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
5. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.
Serhan CN; Maddox JF; Petasis NA; Akritopoulou-Zanze I; Papayianni A; Brady HR; Colgan SP; Madara JL
Biochemistry; 1995 Nov; 34(44):14609-15. PubMed ID: 7578068
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.
Maddox JF; Serhan CN
J Exp Med; 1996 Jan; 183(1):137-46. PubMed ID: 8551217
[TBL] [Abstract][Full Text] [Related]
7. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
Gronert K; Gewirtz A; Madara JL; Serhan CN
J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.
Maddox JF; Colgan SP; Clish CB; Petasis NA; Fokin VV; Serhan CN
FASEB J; 1998 Apr; 12(6):487-94. PubMed ID: 9535221
[TBL] [Abstract][Full Text] [Related]
9. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion.
Nigam S; Fiore S; Luscinskas FW; Serhan CN
J Cell Physiol; 1990 Jun; 143(3):512-23. PubMed ID: 2162850
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Papayianni A; Serhan CN; Brady HR
J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
[TBL] [Abstract][Full Text] [Related]
12. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.
Scalia R; Gefen J; Petasis NA; Serhan CN; Lefer AM
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9967-72. PubMed ID: 9275235
[TBL] [Abstract][Full Text] [Related]
14. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity.
Serhan CN; Levy BD; Clish CB; Gronert K; Chiang N
Ernst Schering Res Found Workshop; 2000; (31):143-85. PubMed ID: 10943332
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation.
Gronert K; Colgan SP; Serhan CN
J Pharmacol Exp Ther; 1998 Apr; 285(1):252-61. PubMed ID: 9536019
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Lee TH; Horton CE; Kyan-Aung U; Haskard D; Crea AE; Spur BW
Clin Sci (Lond); 1989 Aug; 77(2):195-203. PubMed ID: 2548801
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways.
Serhan CN; Takano T; Maddox JF
Adv Exp Med Biol; 1999; 447():133-49. PubMed ID: 10086190
[No Abstract] [Full Text] [Related]
20. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
